single-use bioreactors
single-use bioreactors
Revolutionary CAR-T Manufacturing Boosts Cancer Treatment Efficacy!
🌟 Discover a groundbreaking CAR-T cell manufacturing process! 🧬 Researchers are enhancing therapies for breast cancer with innovative bioreactors. 💡🔥
Breaking News: Gene Therapy Partnership Expands!
📢 Univercells Technologies and UPENN are expanding their partnership to evaluate gene therapy manufacturing scalability. 🧪 The goal is accessibility and cost reduction. 💪🏭👨🔬
Massachusetts Welcomes Fully Operational Biopharma Powerhouse
📢 Rentschler Biopharma's new production line in Massachusetts is now fully operational. 🏭 The multi-product facility doubles the company's global capacity and focuses on the commercial production of complex molecules. 🔬 The production line includes four new 2,000L single-use bioreactors and adds 22,000 square feet of cleanroom space. 🇺🇸 CEO Benedikt von Braunmühl highlights the company's strong capabilities in the US. 🚀 Rentschler Biopharma contributed to nearly 25 of FDA-approved biopharmaceuticals in 2023.
WuXi Biologics Supercharges Manufacturing with 5000L Bioreactors!
⚡ WuXi Biologics upgrades manufacturing capability with installation of three 5,000L single-use bioreactors! 🏭✨🔝
Revolutionizing Cell Therapy Manufacturing: Faster & Safer
🔎 This article explores the challenges in cell therapy manufacturing and the urgency for faster processes. It discusses closed-process systems, bioreactors, and rapid testing methods to improve efficiency. It emphasizes the significance of streamlined manufacturing and quality control testing for faster treatment delivery. The need for a common manufacturing platform and scalability in cell therapy production is also addressed.
Discover the Surprising Dual Nature of One Bacterium
🔍 Researchers discover a bacterium with dual nature: harmful in hospitals, but with potential in dyeing fabrics and medicine. 🧫💉🌈
Spanish Company Revolutionizes Personalized Medicine
📢 A Spanish company, TECNIC Bioprocess Solutions, has been selected for phase 1 of a pre-commercial public procurement for the development of an intelligent platform for single-use bioreactors. 👨⚕️ The collaboration between TECNIC Bioprocess Solutions and BYOTIC aims to advance personalized medicine and innovative therapies. 🔬 The project focuses on the development of single-use bioreactors for autologous cell therapy, reducing the need for repeated sterilization and contamination risks. 💡 TECNIC's innovative design incorporates advanced perfusion technology and control software for optimal production of cell-based biopharmaceuticals. ♻️ The modular and flexible design of the bioreactors enhances sustainability and adaptability, reducing costs and improving production efficiency. 🤝 Strategic collaborations with leading institutions such as Universitat Autònoma de Barcelona and Banc de Sang i Teixits de Catalunya strengthen research and development capabilities. 💪 This project not only improves personalized treatments but also sets new standards for efficient and safe production of biopharmaceuticals. 🌍 TECNIC's advancements in bioprocessing technology contribute to a future where personalized medicine is accessible to all, transforming healthcare. 💼 TECNIC Bioprocess Solutions' contribution to knowledge creation and technology transfer fosters economic and technological development.
